Wacker Chemie AG

About WACKER Biotech

WACKER Biotech supports therapy developers with microbial CDMO services spanning plasmid DNA, mRNA and lipid nanoparticle formulation. Teams engage from tech transfer and process development through GMP manufacture and onward supply, working with partners to enable downstream steps such as fill-finish. If you are mapping an IND or scaling a program in 2026, use this profile to share your use case, request capacity information and book a meeting in San Diego.

Capabilities

• Plasmid DNA for xRNA applications

• GMP process development and scale-up for mRNA

• LNP formulation and characterisation

• Tech transfer, analytics and comparability support

• Validation planning for clinical and commercial supply